These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17424997)

  • 1. [Nicotinic acid in lipid metabolism disorders].
    Ahmed K; Offermanns S
    Pharm Unserer Zeit; 2007; 36(2):120-5. PubMed ID: 17424997
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic acid: an old drug with a promising future.
    Bodor ET; Offermanns S
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S68-75. PubMed ID: 18037924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enduracin--a nicotinic acid preparation in the treatment of hypercholesterolemia].
    Kardiologiia; 1993; 33(11):67-80. PubMed ID: 8145429
    [No Abstract]   [Full Text] [Related]  

  • 4. What restricts the clinical use of nicotinic acid?
    Kei A; Liberopoulos EN; Elisaf MS
    Curr Vasc Pharmacol; 2011 Jul; 9(4):521-30. PubMed ID: 21314634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist.
    Tang H; Lu JY; Zheng X; Yang Y; Reagan JD
    Biochem Biophys Res Commun; 2008 Oct; 375(4):562-5. PubMed ID: 18722346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New evidence for nicotinic acid treatment to reduce atherosclerosis.
    Montecucco F; Quercioli A; Dallegri F; Viviani GL; Mach F
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1457-67. PubMed ID: 20936932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular pharmacology and medicinal chemistry of fibrate].
    Steinhilber D; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2007; 36(2):108-12. PubMed ID: 17424995
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials.
    Lukasova M; Hanson J; Tunaru S; Offermanns S
    Trends Pharmacol Sci; 2011 Dec; 32(12):700-7. PubMed ID: 21944259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug?
    Pike NB; Wise A
    Curr Opin Investig Drugs; 2004 Mar; 5(3):271-5. PubMed ID: 15083592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HM74a agonists: will they be the new generation of nicotinic acid?
    Martres P
    Curr Top Med Chem; 2009; 9(5):428-35. PubMed ID: 19519459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New targets and drugs for treatment of lipid metabolism disorders].
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2007; 36(2):142-8. PubMed ID: 17425000
    [No Abstract]   [Full Text] [Related]  

  • 12. The nicotinic acid receptor--a new mechanism for an old drug.
    Karpe F; Frayn KN
    Lancet; 2004 Jun; 363(9424):1892-4. PubMed ID: 15183629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia.
    McCormack PL; Keating GM
    Drugs; 2005; 65(18):2719-40. PubMed ID: 16392885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-release niacin for modifying the lipoprotein profile.
    Guyton JR
    Expert Opin Pharmacother; 2004 Jun; 5(6):1385-98. PubMed ID: 15163282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrate in lipid metabolism disorders].
    Kostner KM; Kostner GM
    Pharm Unserer Zeit; 2007; 36(2):114-9. PubMed ID: 17424996
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotinic acid: pharmacological effects and mechanisms of action.
    Gille A; Bodor ET; Ahmed K; Offermanns S
    Annu Rev Pharmacol Toxicol; 2008; 48():79-106. PubMed ID: 17705685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic effects of niacin: Current possibilities for its clinical use.
    Zeman M; Vecka M; Perlík F; Staňková B; Hromádka R; Tvrzická E; Širc J; Hrib J; Žák A
    Acta Pharm; 2016 Dec; 66(4):449-469. PubMed ID: 27749252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niacin: vitamin and antidyslipidemic drug.
    Jacobson EL; Kim H; Kim M; Jacobson MK
    Subcell Biochem; 2012; 56():37-47. PubMed ID: 22116693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus.
    Van JT; Pan J; Wasty T; Chan E; Wu X; Charles MA
    Am J Cardiol; 2002 Jun; 89(11):1306-8. PubMed ID: 12031735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.